Global Cutaneous Squamous Cell Carcinoma Treatment Market to Surpass US$ 16,867.06 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--()--According to Coherent Market Insights, the global Cutaneous Squamous Cell Carcinoma Treatment market is estimated to be valued at US$ 10,309.76 million in 2020 and is expected to exhibit a CAGR of 7.2% during the forecast period (2020-2027).

Key Trends and Analysis:

Key trends in the market include rising incidence of cutaneous squamous cell carcinoma treatment and ongoing research and development for the treatment of cutaneous squamous-cell carcinoma.

Market players are actively focusing on research and development for Cutaneous Squamous Cell Carcinoma Treatment for cost effective and quality treatment. For instance, in June 2018, Regeneron Pharmaceuticals, Inc. and Sanofi A.S. received the U.S. Food and Drug Administration (FDA) approval for Libtayo (cemiplimab), an ointment for the treatment of patients with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC. Libtayo is a fully-human monoclonal antibody targeting the immune checkpoint receptor PD-1 (programmed cell death protein-1) and is the first and only treatment specifically approved and available for advanced cSCC in the U.S.

However, longer duration and higher cost of the surgery are the factors that are expected to hinder the market growth. For instance, according to the Hindawi Limited, an open access journal publishers, stated that curettage and electrodessication are destructive surgeries, as often these are used to treat superficial low risk cSCCs on the trunk and extremities. The surgery leaves a cigarette burn-like scar. After this surgery, tumor may recur at the site, needing additional procedures.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4280

Key Market Takeaways:

The global cutaneous squamous cell carcinoma treatment market is expected to exhibit a CAGR of 7.2% during the forecast period, owing to rising incidence of cutaneous squamous-cell carcinoma globally. For instance, according to the American Cancer Society, Inc., an article published in January 2020, reports that about 5.4 million basal and squamous cell skin cancers are diagnosed each year in the U.S.

Key players in the markets are focusing on collaboration for the commercialization of cutaneous squamous cell carcinoma treatment, which is expected to propel the market growth during the forecast period. For instance, in April 2015, Bristol-Myers Squibb and Eli Lilly and Company entered into a collaboration to commercialize Erbitux (cetuximab), an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of locally or regionally advanced squamous cell carcinoma of the head and neck in North America. Under this collaboration Bristol-Myers Squibb transferred full commercialization and manufacturing operational responsibilities of Erbitux to Eli Lilly and Company.

Competitive Landscape:

Key players operating in the global cutaneous squamous cell carcinoma treatment market include Eli Lilly and Company, Sanofi S.A., Cadila Healthcare Limited, Cipla Limited, Castle Biosciences, Regeneron Pharmaceuticals, Inc., Merck & Co., Inc., Vidac Pharma, LEO Pharma A/S, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme, and Amgen Inc. among others.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4280

Market Segmentation:

  • Global Cutaneous Squamous Cell Carcinoma Treatment Market, By Treatment:
    • Surgical
      • Moh’s Micrographic Surgery (MMS)
      • Electrodessication or Curettage
    • Non-surgical
      • Chemotherapy
      • Topical Immune Response Modifiers
      • Radiotherapy
      • Systemic Chemotherapy
  • Global Cutaneous Squamous Cell Carcinoma Treatment Market, By Application:
    • Hospitals
    • Cancer Institutes
    • Ambulatory Surgical Centers
    • Others
  • Global Cutaneous Squamous Cell Carcinoma Treatment Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Report:

Pet Cancer Therapeutics Market, by Therapy Type (Chemotherapy, Targeted Therapy, Combination Therapy, and Immunotherapy), by Pet Type (Cat, Dog, and Horse), by Mode of Administration (Oral, Intravenous, and Topical), by Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others) and by Region - Global Trends, and Forecast till 2025

Read more: https://www.coherentmarketinsights.com/market-insight/pet-cancer-therapeutics-market-1284

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Release Summary

The global cutaneous squamous cell carcinoma treatment market is poised to grow at a CAGR of 7.2% during the forecast period 2020-2027.

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter